Jeffrey P. Simko

943 total citations
16 papers, 629 citations indexed

About

Jeffrey P. Simko is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Jeffrey P. Simko has authored 16 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Jeffrey P. Simko's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Immunotherapy and Immune Responses (4 papers). Jeffrey P. Simko is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Immunotherapy and Immune Responses (4 papers). Jeffrey P. Simko collaborates with scholars based in United States, Australia and Italy. Jeffrey P. Simko's co-authors include Peter R. Carroll, Vivian Weinberg, Lawrence Fong, Eric J. Small, Robert A. Stephenson, John M. Corman, Yafei Hou, Serena S. Kwek, Robert B. Sims and Christopher L. Amling and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Jeffrey P. Simko

16 papers receiving 619 citations

Peers

Jeffrey P. Simko
Kumaran Mudaliar United States
Gregory Pennock United States
A.L. Zietman United States
Kumaran Mudaliar United States
Jeffrey P. Simko
Citations per year, relative to Jeffrey P. Simko Jeffrey P. Simko (= 1×) peers Kumaran Mudaliar

Countries citing papers authored by Jeffrey P. Simko

Since Specialization
Citations

This map shows the geographic impact of Jeffrey P. Simko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey P. Simko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey P. Simko more than expected).

Fields of papers citing papers by Jeffrey P. Simko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey P. Simko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey P. Simko. The network helps show where Jeffrey P. Simko may publish in the future.

Co-authorship network of co-authors of Jeffrey P. Simko

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey P. Simko. A scholar is included among the top collaborators of Jeffrey P. Simko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey P. Simko. Jeffrey P. Simko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Sumiyoshi, Takayuki, Xiaofei Wang, Evan W. Warner, et al.. (2023). Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial. JNCI Journal of the National Cancer Institute. 116(1). 115–126. 2 indexed citations
2.
Lindquist, Karla, Pamela L. Paris, Thomas J. Hoffmann, et al.. (2016). Mutational Landscape of Aggressive Prostate Tumors in African American Men. Cancer Research. 76(7). 1860–1868. 54 indexed citations
3.
Lotan, Tamara L., Wei Wei, Carlos L. Morais, et al.. (2015). PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer. European Urology Focus. 2(2). 180–188. 52 indexed citations
4.
Fong, Lawrence, Peter R. Carroll, Vivian Weinberg, et al.. (2014). Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer. JNCI Journal of the National Cancer Institute. 106(11). 163 indexed citations
5.
Wang, Siao‐Yi, Stephen Shiboski, Cassandra D. Belair, et al.. (2014). miR-19, miR-345, miR-519c-5p Serum Levels Predict Adverse Pathology in Prostate Cancer Patients Eligible for Active Surveillance. PLoS ONE. 9(6). e98597–e98597. 46 indexed citations
6.
Magbanua, Mark Jesus M., Erin L. Richman, Eduardo V. Sosa, et al.. (2012). Physical activity and prostate gene expression in men with low-risk prostate cancer.. Journal of Clinical Oncology. 30(5_suppl). 189–189. 2 indexed citations
7.
Fong, Lawrence, Vivian Weinberg, John M. Corman, et al.. (2012). Immune responses in prostate tumor tissue following neoadjuvant sipuleucel-T in patients with localized prostate cancer.. Journal of Clinical Oncology. 30(5_suppl). 181–181. 9 indexed citations
8.
Kwek, Serena S., Vinh Dao, Ritu Roy, et al.. (2012). Diversity of Antigen-Specific Responses Induced In Vivo with CTLA-4 Blockade in Prostate Cancer Patients. The Journal of Immunology. 189(7). 3759–3766. 61 indexed citations
9.
Fong, Lawrence, Vivian Weinberg, John M. Corman, et al.. (2012). Neoadjuvant sipuleucel-T in localized prostate cancer: Effects on immune cells within the prostate tumor microenvironment.. Journal of Clinical Oncology. 30(15_suppl). 2564–2564. 11 indexed citations
10.
Cooperberg, Matthew R., Jeffrey P. Simko, Janet E. Cowan, et al.. (2012). Validation of a panel of cell-cycle progression genes for improved risk stratification in a contemporary radical prostatectomy cohort.. Journal of Clinical Oncology. 30(5_suppl). 10–10. 3 indexed citations
11.
Dall’Era, Marc, Janet E. Cowan, Jeffrey P. Simko, et al.. (2010). Surgical management after active surveillance for low‐risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment. British Journal of Urology. 107(8). 1232–1237. 63 indexed citations
12.
Hou, Yafei, Jason DeVoss, Serena S. Kwek, et al.. (2009). An aberrant prostate antigen–specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans. Journal of Clinical Investigation. 119(7). 2031–41. 47 indexed citations
13.
Ryan, Charles J., Christopher M. Haqq, Jeffrey P. Simko, et al.. (2007). Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer. Urologic Oncology Seminars and Original Investigations. 25(2). 134–140. 49 indexed citations
14.
Davies, Benjamin J., et al.. (2007). 1778: Clinical Predictors of Unifocal Prostate Cancer: Implications for Local Ablative Therapy. The Journal of Urology. 177(4S). 591–591. 1 indexed citations
15.
Paris, Pamela L., Matthias D. Hofer, Giancarlo Albo, et al.. (2006). Genomic Profiling of Hormone-Naïve Lymph Node Metastases in Patients with Prostate Cancer. Neoplasia. 8(12). 1083–IN35. 20 indexed citations
16.
Master, Viraj A., Thomas Chi, Jeffrey P. Simko, Vivian Weinberg, & Peter R. Carroll. (2005). THE INDEPENDENT IMPACT OF EXTENDED PATTERN BIOPSY ON PROSTATE CANCER STAGE MIGRATION. The Journal of Urology. 174(5). 1789–1793. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026